Skip to main content
Top
Published in: Annals of Surgical Oncology 6/2018

01-06-2018 | Bone and Soft Tissue Sarcomas

Adequate Local Control in High-Risk Soft Tissue Sarcoma of the Extremity Treated with Surgery Alone at a Reference Centre: Should Radiotherapy Still be a Standard?

Authors: Marco Fiore, MD, Samuel Ford, MD, Dario Callegaro, MD, Claudia Sangalli, MD, Chiara Colombo, MD, Stefano Radaelli, MD, Anna Maria Frezza, MD, Salvatore L. Renne, MD, Paolo G. Casali, MD, Alessandro Gronchi, MD

Published in: Annals of Surgical Oncology | Issue 6/2018

Login to get access

Abstract

Background

Established practice for the management of soft tissue sarcoma (STS) of the extremity and trunk wall combines perioperative radiotherapy (RT) with limb-preserving surgery.

Objective

The aim of this study was to explore whether high-quality surgery at high-volume centers may offer equivalent local control in selected cases, when RT needs to be avoided.

Methods

All consecutive adult cases of primary, high-risk STSs treated in a high-volume reference center over a 12-year timeframe were included, and, on retrospective analysis, were divided into two groups. Group A received RT with surgery, and Group B received surgery alone. The primary endpoint was local recurrence-free survival (LRFS).

Results

Overall, 390 patients were included (318 in Group A and 72 in Group B), with a median follow-up of 53 months. The main reasons for avoiding RT were patient choice and technical considerations (vascular bypass or flap reconstruction). No difference in R0 resection was seen between the groups (79% vs. 70%; p = 0.18), but Group A had more G3 tumors (80.5% vs. 68%; p = 0.021). No difference in 5-year LRFS was evident (84% vs. 81%; p = 0.16).

Conclusions

LRFS did not differ between patients with high-risk STSs receiving perioperative RT and those treated with surgery alone. The study was retrospective and omission of RT was largely uncontrolled with inherent bias. Nonetheless, data suggest that in experienced centers, the omission of RT did not diminish local disease outcome. Future studies on a selective approach to RT administration are awaited.
Literature
1.
go back to reference Lindberg RD, Martin RG, Romsdahl MM, Barkley HT Jr. Conservative surgery and postoperative radiotherapy in 300 adults with soft-tissue sarcomas. Cancer. 1981:47:2391–97.CrossRefPubMed Lindberg RD, Martin RG, Romsdahl MM, Barkley HT Jr. Conservative surgery and postoperative radiotherapy in 300 adults with soft-tissue sarcomas. Cancer. 1981:47:2391–97.CrossRefPubMed
2.
go back to reference Herbert SH, Corn BW, Solin LJ, Lanciano RM, Schultz DJ, McKenna WG, et al. Limb-preserving treatment for soft tissue sarcomas of the extremities. The significance of surgical margins. Cancer. 1993:72:1230–38.PubMed Herbert SH, Corn BW, Solin LJ, Lanciano RM, Schultz DJ, McKenna WG, et al. Limb-preserving treatment for soft tissue sarcomas of the extremities. The significance of surgical margins. Cancer. 1993:72:1230–38.PubMed
3.
go back to reference Karakousis CP, Proimakis C, Walsh DL. Primary soft tissue sarcoma of the extremities in adults. Br J Surg. 1995:82:1208–12.CrossRefPubMed Karakousis CP, Proimakis C, Walsh DL. Primary soft tissue sarcoma of the extremities in adults. Br J Surg. 1995:82:1208–12.CrossRefPubMed
4.
go back to reference Wilson AN, Davis A, Bell RS et. al. Local control of soft tissue sarcoma of the extremity: the experience of a multidisciplinary sarcoma group with definitive surgery and radiotherapy. Eur J Cancer. 1994:30A:746–51.CrossRefPubMed Wilson AN, Davis A, Bell RS et. al. Local control of soft tissue sarcoma of the extremity: the experience of a multidisciplinary sarcoma group with definitive surgery and radiotherapy. Eur J Cancer. 1994:30A:746–51.CrossRefPubMed
5.
go back to reference Fein DA, Lee WR, Lanciano RM et. al. Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation: do total dose, overall treatment time, and the surgery-radiotherapy interval impact on local control? Int J Radiat Oncol Biol Phys. 1995:32:969–76.CrossRefPubMed Fein DA, Lee WR, Lanciano RM et. al. Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation: do total dose, overall treatment time, and the surgery-radiotherapy interval impact on local control? Int J Radiat Oncol Biol Phys. 1995:32:969–76.CrossRefPubMed
6.
go back to reference Mundt AJ, Awan A, Sibley GS, et. al. Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: clinical and radiobiological results. Int J Radiat Oncol Biol Phys. 1995:32:977–85.CrossRefPubMed Mundt AJ, Awan A, Sibley GS, et. al. Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: clinical and radiobiological results. Int J Radiat Oncol Biol Phys. 1995:32:977–85.CrossRefPubMed
7.
go back to reference Rosenberg SA, Tepper J, Glatstein E et. al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982:196:305–15.CrossRefPubMedPubMedCentral Rosenberg SA, Tepper J, Glatstein E et. al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982:196:305–15.CrossRefPubMedPubMedCentral
8.
go back to reference Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996:14:859–68.CrossRefPubMed Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996:14:859–68.CrossRefPubMed
9.
go back to reference Gronchi A, Miceli R, Fiore M et. al. Extremity soft tissue sarcoma: adding to the prognostic meaning of local failure. Ann Surg Oncol. 2007:14:1583–90.CrossRefPubMed Gronchi A, Miceli R, Fiore M et. al. Extremity soft tissue sarcoma: adding to the prognostic meaning of local failure. Ann Surg Oncol. 2007:14:1583–90.CrossRefPubMed
10.
go back to reference Tanabe KK, Pollock RE, Ellis LM, Murphy A, Sherman N, Romsdahl MM. Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas. Cancer. 1994:73:1652–59.CrossRefPubMed Tanabe KK, Pollock RE, Ellis LM, Murphy A, Sherman N, Romsdahl MM. Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas. Cancer. 1994:73:1652–59.CrossRefPubMed
11.
go back to reference Mariani L, Miceli R, Kattan MW, et. al. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer. 2005:103:402–8.CrossRefPubMed Mariani L, Miceli R, Kattan MW, et. al. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer. 2005:103:402–8.CrossRefPubMed
12.
go back to reference Callegaro D, Miceli R, Bonvalot S, et. al. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. Lancet Oncol. 2016:17:671–680.CrossRefPubMed Callegaro D, Miceli R, Bonvalot S, et. al. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. Lancet Oncol. 2016:17:671–680.CrossRefPubMed
13.
go back to reference ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014:25 Suppl 3:iii102–12. ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014:25 Suppl 3:iii102–12.
14.
go back to reference Gronchi A, Ferrari S, Quagliuolo V, et. al. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. 2017:18:812–822.CrossRefPubMed Gronchi A, Ferrari S, Quagliuolo V, et. al. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. 2017:18:812–822.CrossRefPubMed
15.
go back to reference Khanfir K, Alzieu L, Terrier P, Le Pechoux C, Bonvalot S, Vanel D, et al. Does adjuvant radiation therapy increase loco-regional control after optimal resection of soft-tissue sarcoma of the extremities? Eur J Cancer. 2003:39:1872–80.CrossRefPubMed Khanfir K, Alzieu L, Terrier P, Le Pechoux C, Bonvalot S, Vanel D, et al. Does adjuvant radiation therapy increase loco-regional control after optimal resection of soft-tissue sarcoma of the extremities? Eur J Cancer. 2003:39:1872–80.CrossRefPubMed
16.
go back to reference Baldini EH, Goldberg J, Jenner C, Manola JB, Demetri GD, Fletcher CD, et al. Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk. J Clin Oncol. 1999:17:3252–59.CrossRefPubMed Baldini EH, Goldberg J, Jenner C, Manola JB, Demetri GD, Fletcher CD, et al. Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk. J Clin Oncol. 1999:17:3252–59.CrossRefPubMed
17.
go back to reference Pisters PW, Pollock RE, Lewis VO, et. al. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg. 2007:246:675–81; discussion 681–2. Pisters PW, Pollock RE, Lewis VO, et. al. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg. 2007:246:675–81; discussion 681–2.
18.
go back to reference Yang JC, Chang AE, Baker AR, et. al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998: 6:197–203.CrossRef Yang JC, Chang AE, Baker AR, et. al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998: 6:197–203.CrossRef
19.
go back to reference Davis AM, O’Sullivan B, Turcotte R, et. al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005:75:48–53.CrossRefPubMed Davis AM, O’Sullivan B, Turcotte R, et. al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005:75:48–53.CrossRefPubMed
20.
go back to reference Radaelli S, Fiore M, Colombo C, et. al. Vascular resection en-bloc with tumor removal and graft reconstruction is safe and effective in soft tissue sarcoma (STS) of the extremities and retroperitoneum. Surg Oncol. 2016:25:125–31.CrossRefPubMed Radaelli S, Fiore M, Colombo C, et. al. Vascular resection en-bloc with tumor removal and graft reconstruction is safe and effective in soft tissue sarcoma (STS) of the extremities and retroperitoneum. Surg Oncol. 2016:25:125–31.CrossRefPubMed
21.
go back to reference Gronchi A, Miceli R, Colombo C, et. al. Primary extremity soft tissue sarcomas: outcome improvement over time at a single institution. Ann Oncol. 2011:22:1675–81.CrossRefPubMed Gronchi A, Miceli R, Colombo C, et. al. Primary extremity soft tissue sarcomas: outcome improvement over time at a single institution. Ann Oncol. 2011:22:1675–81.CrossRefPubMed
22.
go back to reference Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996:14:1679–89.CrossRefPubMed Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996:14:1679–89.CrossRefPubMed
23.
go back to reference Marubini E, Valsecchi M (eds). Analysing survival data for clinical trials and observational studies. Chichester: Wiley; 1995. Marubini E, Valsecchi M (eds). Analysing survival data for clinical trials and observational studies. Chichester: Wiley; 1995.
24.
go back to reference Alektiar KM, Velasco J, Zelefsky MJ, Woodruff JM, Lewis JJ, Brennan MF. Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys. 2000:48:1051–58.CrossRefPubMed Alektiar KM, Velasco J, Zelefsky MJ, Woodruff JM, Lewis JJ, Brennan MF. Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys. 2000:48:1051–58.CrossRefPubMed
25.
go back to reference Gronchi A, Verderio P, De Paoli A, et al. Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall. Ann Oncol. 2013:24:817–23.CrossRefPubMed Gronchi A, Verderio P, De Paoli A, et al. Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall. Ann Oncol. 2013:24:817–23.CrossRefPubMed
26.
go back to reference Cahlon O, Spierer M, Brennan MF, Singer S, Alektiar KM. Long-term outcomes in extremity soft tissue sarcoma after a pathologically negative re-resection and without radiotherapy. Cancer. 2008:112:2774–79.CrossRefPubMed Cahlon O, Spierer M, Brennan MF, Singer S, Alektiar KM. Long-term outcomes in extremity soft tissue sarcoma after a pathologically negative re-resection and without radiotherapy. Cancer. 2008:112:2774–79.CrossRefPubMed
27.
go back to reference Bagaria SP, Ashman JB, Daugherty LC, Gray RJ, Wasif N. Compliance with National Comprehensive Cancer Network guidelines in the use of radiation therapy for extremity and superficial trunk soft tissue sarcoma in the United States. J Surg Oncol. 2014:109:633–38.CrossRefPubMed Bagaria SP, Ashman JB, Daugherty LC, Gray RJ, Wasif N. Compliance with National Comprehensive Cancer Network guidelines in the use of radiation therapy for extremity and superficial trunk soft tissue sarcoma in the United States. J Surg Oncol. 2014:109:633–38.CrossRefPubMed
28.
go back to reference Kachare SD, Brinkley J, Vohra NA, Zervos EE, Wong JH, Fitzgerald TL. Radiotherapy associated with improved survival for high-grade sarcoma of the extremity. J Surg Oncol. 2015:112:338–43.CrossRefPubMed Kachare SD, Brinkley J, Vohra NA, Zervos EE, Wong JH, Fitzgerald TL. Radiotherapy associated with improved survival for high-grade sarcoma of the extremity. J Surg Oncol. 2015:112:338–43.CrossRefPubMed
29.
go back to reference Baxter KJ, Govsyeyev N, Namm JP, Gonzalez RJ, Roggin KK, Cardona K. Is multimodality therapy necessary for the management of pure myxoid liposarcomas? A multi-institutional series of pure myxoid liposarcomas of the extremities and torso. J Surg Oncol. 2015:111:146–51.CrossRefPubMed Baxter KJ, Govsyeyev N, Namm JP, Gonzalez RJ, Roggin KK, Cardona K. Is multimodality therapy necessary for the management of pure myxoid liposarcomas? A multi-institutional series of pure myxoid liposarcomas of the extremities and torso. J Surg Oncol. 2015:111:146–51.CrossRefPubMed
30.
go back to reference Gronchi A. Individualizing the use/non-use of radiation therapy (RT) in soft tissue sarcoma (STS): when abstention is better than care. J Surg Oncol. 2015:111:133–34.CrossRefPubMed Gronchi A. Individualizing the use/non-use of radiation therapy (RT) in soft tissue sarcoma (STS): when abstention is better than care. J Surg Oncol. 2015:111:133–34.CrossRefPubMed
31.
go back to reference Tiong SS, Dickie C, Haas RL, O’Sullivan B. The role of radiotherapy in the management of localized soft tissue sarcomas. Cancer Biol Med. 2016:13:373–83.CrossRefPubMedPubMedCentral Tiong SS, Dickie C, Haas RL, O’Sullivan B. The role of radiotherapy in the management of localized soft tissue sarcomas. Cancer Biol Med. 2016:13:373–83.CrossRefPubMedPubMedCentral
32.
go back to reference McKee MD, Liu DF, Brooks JJ, Gibbs JF, Driscoll DL, Kraybill WG. The prognostic significance of margin width for extremity and trunk sarcoma. J Surg Oncol. 2004:85:68–76.CrossRefPubMed McKee MD, Liu DF, Brooks JJ, Gibbs JF, Driscoll DL, Kraybill WG. The prognostic significance of margin width for extremity and trunk sarcoma. J Surg Oncol. 2004:85:68–76.CrossRefPubMed
33.
go back to reference Jebsen NL, Trovik CS, Bauer HC, et. al. Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study. Int J Radiat Oncol Biol Phys. 2008:71:1196–203.CrossRefPubMed Jebsen NL, Trovik CS, Bauer HC, et. al. Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study. Int J Radiat Oncol Biol Phys. 2008:71:1196–203.CrossRefPubMed
Metadata
Title
Adequate Local Control in High-Risk Soft Tissue Sarcoma of the Extremity Treated with Surgery Alone at a Reference Centre: Should Radiotherapy Still be a Standard?
Authors
Marco Fiore, MD
Samuel Ford, MD
Dario Callegaro, MD
Claudia Sangalli, MD
Chiara Colombo, MD
Stefano Radaelli, MD
Anna Maria Frezza, MD
Salvatore L. Renne, MD
Paolo G. Casali, MD
Alessandro Gronchi, MD
Publication date
01-06-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 6/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6393-x

Other articles of this Issue 6/2018

Annals of Surgical Oncology 6/2018 Go to the issue